Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
Evaluate the acceptability over 24 hours of a new paracetamol formulation 4.8% paediatric
oral suspension in children weighing between 3 and 26 kg including limits